The biotech industry raised $36.2 billion last year, excluding partnership monies—the most since the genomics bubble of 2000. The tally was helped by several large debt deals, with eight companies raising >$1 billion each and a total raised of $22.4 billion—up 131% from 2009. Initial public offerings also heated up, with 31 biotechs raising $1.6 billion versus 10 raising $928 million in 2009.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, W. 2010—bumper year for big biotech. Nat Biotechnol 29, 102 (2011). https://doi.org/10.1038/nbt.1777
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1777
